12974_2021_2301_MOESM1_ESM.tiff (319.05 kB)
Additional file 1 of Autoantibody screening in Guillain–Barré syndrome
figure
posted on 2021-11-01, 04:19 authored by Cinta Lleixà, Lorena Martín-Aguilar, Elba Pascual-Goñi, Teresa Franco, Marta Caballero, Noemí de Luna, Eduard Gallardo, Xavier Suárez-Calvet, Laura Martínez-Martínez, Jordi Diaz-Manera, Ricard Rojas-García, Elena Cortés-Vicente, Joana Turón, Carlos Casasnovas, Christian Homedes, Gerardo Gutiérrez-Gutiérrez, María Concepción Jimeno-Montero, José Berciano, Maria José Sedano-Tous, Tania García-Sobrino, Julio Pardo-Fernández, Celedonio Márquez-Infante, Iñigo Rojas-Marcos, Ivonne Jericó-Pascual, Eugenia Martínez-Hernández, Germán Morís de la Tassa, Cristina Domínguez-González, Cándido Juárez, Isabel Illa, Luis QuerolAdditional file 1: Figure 1. Heatmap showing anti-ganglioside antibodies in the GBS cohort. Patients and reactivities against anti-ganglioside antibodies are ordered according to Euclidean clustering. Each row represents one GBS patient. The score of the anti-ganglioside titre is indicated by the colour of the square (0 = < 1/1000, 1 = 1/1000–1/2500, 2 = 1/2500–1/12500, 3 = > 1/12500). Columns in the left contain information related to the clinical variant and the outcome at 6 months and at 1 year of follow-up.
